Zhao, Qi
Ma, Ya
Zhou, Xiao
Wang, Ruikang
Yang, Wenli
Peng, Xiaoyan
Wei, Wenbin
Funding for this research was provided by:
National Natural Science Foundation of China (82171073, 81570891)
Article History
Received: 14 February 2024
Accepted: 24 May 2025
First Online: 6 September 2025
Declarations
:
: The authors report no potential conflicts of interest. Professor Ruikang Wang discloses intellectual property owned by the Oregon Health and Science University and the University of Washington. He is a consultant to Carl Zeiss Meditec, Inc. and receives research support from Research to Prevent Blindness, Carl Zeiss Meditec Inc., and Colgate Palmolive Company.
: This study had ethics approval from Research Ethics Committee of Beijing Tongren Hospital, Capital Medical University. Written informed consent was obtained from all individual participants.
: This paper has not been published elsewhere. It is not currently under consideration for publication elsewhere.